Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ONON vs GSK✓SelectedUSD · GSKONON vs GSK performance historyLatest closeAs of-2.78%11/17
Stock and ETF performance explorer

ONON vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.1%
GSK return
+43.9%
Excess return
-82.0%
Maximum drawdown
-68.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-2.3%-0.5%-2.3%
7D-8.2%-3.0%-5.2%-7.6%
30D-8.3%+0.4%-8.7%-8.4%
3M+1.7%-1.2%+2.9%+1.9%
6M-14.5%+0.9%-15.5%-14.7%
YTD-31.5%+4.0%-35.5%-32.1%
1Y-23.1%+7.3%-30.4%-24.2%
3Y+15.4%+57.1%-41.7%+0.1%
5Y-38.1%+43.0%-81.0%-55.8%
All-38.1%+43.9%-82.0%-55.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling